dennis selkoe, md: crenezumab significantly reduces aβ oligomers in csf
Published 6 years ago • 378 plays • Length 3:44Download video MP4
Download video MP3
Similar videos
-
5:52
dennis selkoe, md: current challenges in alzheimer disease and hope for the future
-
1:10:41
recent biological insights in alzheimer's and parkinson's diseases - prof dennis selkoe
-
2:26
csf protein panels reflect the specific molecular fingerprint of alzheimer's disease
-
1:00:18
aging and alzheimer's disease
-
2:19
vamp-2 as a csf marker of cognitive decline in alzheimer’s disease
-
47:06
cerebro spinal fluid leak: diagnosis and surgical treatment
-
2:47
claire henchcliffe, md, dphil: dopaminergic cell replenishment in parkinson disease
-
5:37
targeting the earliest signs of alzheimer’s disease: the zilkha neurogenetic institute
-
6:10
donia wheelan - life with a cerebrospinal fluid (csf) leak
-
34:30
intro to neuropsychological assessment
-
4:07
parkinsons disease and end of life care
-
1:25
neuroinflammation and synapse loss in alzheimer’s disease
-
28:01
alzheimer's disease: spotlight on stem cell research - frank laferla
-
1:24:01
the dementias: new biology, public health applications
-
1:19
ask the md: what is alpha-synuclein?
-
36:20
neuroccino 13th december 2021 - neural correlates of anosognosia in alzheimer's disease
-
55:54
alzheimer's disease with thomas c. südhof
-
1:28
meet joseph ciacci, md: uc san diego cirm alpha stem cell clinic